An Investigation on the Effect of Polyethylene Oxide Concentration and Particle Size in Modulating Theophylline Release from Tablet Matrices

Overview

Journal AAPS PharmSciTech

Publisher Springer

Specialty Pharmacology

Date 2015 Mar 17

PMID 25771738

Authors

Saeed Shojaee

Parastou Emami

Ahmad Mahmood

Yemisi Rowaiye

Alusine Dukulay

Waseem Kaialy

Iain Cumming

Ali Nokhodchi

Affiliations

Soon will be listed here.

Abstract

Polyethylene oxide has been researched extensively as an alternative polymer to hydroxypropyl methylcellulose (HPMC) in controlled drug delivery due to its desirable swelling properties and its availability in a number of different viscosity grades. Previous studies on HPMC have pointed out the importance of particle size on drug release, but as of yet, no studies have investigated the effect of particle size of polyethylene oxide (polyox) on drug release. The present study explored the relationship between polymer level and particle size to sustain the drug release. Tablets produced contained theophylline as their active ingredient and consisted of different polyethylene oxide particle size fractions (20-45, 45-90, 90-180 and 180-425 μm). It was shown that matrices containing smaller particle sizes of polyox produced harder tablets than when larger polyox particles were used. The release studies showed that matrices consisting of large polyox particles showed a faster release rate than matrices made from smaller particles. Molecular weight (MW) of the polymer was a key determining step in attaining sustained release, with the high MW of polyox resulting in a delayed release profile. The results showed that the effect of particle size on drug release was more detrimental when a low concentration of polyox was used. This indicates that care must be taken when low levels of polyox with different particle size fractions are used. More robust formulations could be obtained when the concentration of polyox is high. Differential scanning calorimetry (DSC) traces showed that particle size had no major effect on the thermal behaviour of polyox particles.

References

Velasco M, Ford J, Rowe P, Rajabi-Siahboomi A . Influence of drug:hydroxypropylmethylcellulose ratio, drug and polymer particle size and compression force on the release of diclofenac sodium from HPMC tablets. J Control Release. 1998; 57(1):75-85. DOI: 10.1016/s0168-3659(98)00110-2. View

Lotfipour F, Nokhodchi A, Saeedi M, Norouzi-Sani S, Sharbafi J, Siahi-Shadbad M . The effect of hydrophilic and lipophilic polymers and fillers on the release rate of atenolol from HPMC matrices. Farmaco. 2004; 59(10):819-25. DOI: 10.1016/j.farmac.2004.06.006. View

Akbari J, Nokhodchi A, Farid D, Adrangui M, Siahi-Shadbad M, Saeedi M . Development and evaluation of buccoadhesive propranolol hydrochloride tablet formulations: effect of fillers. Farmaco. 2004; 59(2):155-61. DOI: 10.1016/j.farmac.2003.11.011. View

Al-Khattawi A, Iyire A, Dennison T, Dahmash E, Bailey C, Smith J . Systematic screening of compressed ODT excipients: cellulosic versus non-cellulosic. Curr Drug Deliv. 2014; 11(4):486-500. DOI: 10.2174/1567201811666140323201650. View

Sabnis S, Adeyeye C . Controlled-release hydrophilic tablets for individualized theophylline therapy. Drug Dev Ind Pharm. 1999; 25(2):187-96. DOI: 10.1081/ddc-100102159. View

Kiss D, Suvegh K, Marek T, Devenyi L, Novak C, Zelko R . Tracking the physical aging of poly(ethylene oxide): a technical note. AAPS PharmSciTech. 2007; 7(4):95. PMC: 2750332. DOI: 10.1208/pt070495. View

Colombo P, Bettini R, Massimo G, Catellani P, Santi P, Peppas N . Drug diffusion front movement is important in drug release control from swellable matrix tablets. J Pharm Sci. 1995; 84(8):991-7. DOI: 10.1002/jps.2600840816. View

Di Colo G, Burgalassi S, Chetoni P, Fiaschi M, Zambito Y, Saettone M . Relevance of polymer molecular weight to the in vitro/in vivo performances of ocular inserts based on poly(ethylene oxide). Int J Pharm. 2001; 220(1-2):169-77. DOI: 10.1016/s0378-5173(01)00668-8. View

Maggi L, Segale L, Torre M, Ochoa M, Conte U . Dissolution behaviour of hydrophilic matrix tablets containing two different polyethylene oxides (PEOs) for the controlled release of a water-soluble drug. Dimensionality study. Biomaterials. 2002; 23(4):1113-9. DOI: 10.1016/s0142-9612(01)00223-x. View

10.

Asare-Addo K, Levina M, Rajabi-Siahboomi A, Nokhodchi A . Study of dissolution hydrodynamic conditions versus drug release from hypromellose matrices: the influence of agitation sequence. Colloids Surf B Biointerfaces. 2010; 81(2):452-60. DOI: 10.1016/j.colsurfb.2010.07.040. View

11.

Liew C, Chan L, Ling Ching A, Heng P . Evaluation of sodium alginate as drug release modifier in matrix tablets. Int J Pharm. 2005; 309(1-2):25-37. DOI: 10.1016/j.ijpharm.2005.10.040. View

12.

Kim C . Drug release from compressed hydrophilic POLYOX-WSR tablets. J Pharm Sci. 1995; 84(3):303-6. DOI: 10.1002/jps.2600840308. View

13.

Apicella A, Cappello B, Del Nobile M, La Rotonda M, Mensitieri G, Nicolais L . Poly(ethylene oxide) (PEO) and different molecular weight PEO blends monolithic devices for drug release. Biomaterials. 1993; 14(2):83-90. DOI: 10.1016/0142-9612(93)90215-n. View

14.

Khan K . The concept of dissolution efficiency. J Pharm Pharmacol. 1975; 27(1):48-9. DOI: 10.1111/j.2042-7158.1975.tb09378.x. View

15.

Zhang F, McGinity J . Properties of sustained-release tablets prepared by hot-melt extrusion. Pharm Dev Technol. 1999; 4(2):241-50. DOI: 10.1081/pdt-100101358. View

16.

de Haan P, Lerk C . Oral controlled release dosage forms. A review. Pharm Weekbl Sci. 1984; 6(2):57-67. DOI: 10.1007/BF01953956. View

17.

Dimitrov M, Lambov N . Study of Verapamil hydrochloride release from compressed hydrophilic Polyox-Wsr tablets. Int J Pharm. 1999; 189(1):105-11. DOI: 10.1016/s0378-5173(99)00242-2. View

18.

Hiremath P, Saha R . Controlled release hydrophilic matrix tablet formulations of isoniazid: design and in vitro studies. AAPS PharmSciTech. 2008; 9(4):1171-8. PMC: 2628280. DOI: 10.1208/s12249-008-9159-0. View

19.

Wu N, Wang L, Tan D, Moochhala S, Yang Y . Mathematical modeling and in vitro study of controlled drug release via a highly swellable and dissoluble polymer matrix: polyethylene oxide with high molecular weights. J Control Release. 2005; 102(3):569-81. DOI: 10.1016/j.jconrel.2004.11.002. View

20.

Boyapally H, Nukala R, Bhujbal P, Douroumis D . Controlled release from directly compressible theophylline buccal tablets. Colloids Surf B Biointerfaces. 2010; 77(2):227-33. DOI: 10.1016/j.colsurfb.2010.01.031. View